Camber Capital Management as of Dec. 31, 2019
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 28 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Mylan Nv | 10.6 | $208M | 10M | 20.10 | |
| Allergan | 9.7 | $191M | 1.0M | 191.17 | |
| Biogen Idec (BIIB) | 5.3 | $104M | 350k | 296.73 | |
| Gilead Sciences (GILD) | 5.0 | $98M | 1.5M | 64.98 | |
| Tenet Healthcare Corporation (THC) | 4.8 | $95M | 2.5M | 38.03 | |
| Alexion Pharmaceuticals | 4.8 | $95M | 875k | 108.15 | |
| Ascendis Pharma A S (ASND) | 4.7 | $92M | 663k | 139.12 | |
| Brookdale Senior Living (BKD) | 4.6 | $91M | 13M | 7.27 | |
| Perrigo Company (PRGO) | 4.5 | $88M | 1.7M | 51.66 | |
| Alkermes (ALKS) | 4.3 | $84M | 4.1M | 20.40 | |
| Nektar Therapeutics (NKTR) | 4.1 | $81M | 3.8M | 21.59 | |
| Sarepta Therapeutics (SRPT) | 3.9 | $77M | 600k | 129.04 | |
| DaVita (DVA) | 3.8 | $75M | 1.0M | 75.03 | |
| Universal Health Services (UHS) | 3.6 | $72M | 500k | 143.46 | |
| Synthorx | 3.6 | $70M | 1.0M | 69.89 | |
| Momenta Pharmaceuticals | 3.3 | $64M | 3.3M | 19.73 | |
| Hca Holdings (HCA) | 3.0 | $59M | 400k | 147.81 | |
| Global Blood Therapeutics In | 3.0 | $58M | 730k | 79.49 | |
| AMAG Pharmaceuticals | 2.7 | $53M | 4.4M | 12.17 | |
| Atara Biotherapeutics | 2.5 | $49M | 3.0M | 16.47 | |
| Ventas (VTR) | 2.2 | $43M | 750k | 57.74 | |
| Myriad Genetics (MYGN) | 1.4 | $27M | 1.0M | 27.23 | |
| Mednax (MD) | 1.1 | $22M | 790k | 27.79 | |
| Teva Pharmaceutical Industries (TEVA) | 1.0 | $20M | 2.0M | 9.80 | |
| Glycomimetics (GLYC) | 0.9 | $19M | 3.5M | 5.29 | |
| Translate Bio | 0.6 | $12M | 1.5M | 8.14 | |
| Avrobio Ord (AVRO) | 0.6 | $12M | 600k | 20.13 | |
| Sutro Biopharma (STRO) | 0.3 | $6.6M | 600k | 11.00 |
